Lam Research <LRCX.O>: Mizuho Cuts Target Price to $365 From $370
LRCX•Related News
BioCryst says Japan approves Orladeyo for pediatric HAE patients aged 2-11
BCRX•
Iran vows to resist widened US sanctions, says Washington seeks talks
XLE•
Scotiabank 2026 capital report shows total capitalization at CAD 97.54 billion
BNS•
Incannex doses first patient in Phase 2 DReAMzz trial of IHL-42X for sleep apnea
IXHL•
Dick’s FY26 Q2 EPS falls 26% to $3.50; net sales rise 53.2% to $5.59 billion
DKS•